Semaglutide (Wegovy) Treatment for Trichotillomania | MicrobiomeTrials← Back to trialsNCT07282769
Semaglutide (Wegovy) Treatment for Trichotillomania
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-06Est. Completion: 2027-02
Enrollment target: 10 participants Other microbiome trials you might be interested in
Borderline Personality Disorder
The primary objective of the proposed study is to evaluate the safety and efficacy of Caplyta (lumateperone) in adults w…
Chicago, United StatesCompleted Dec 31, 2025
Skin-PickingTrichotillomania (Hair-Pulling Disorder)
The goal of the proposed study is to compare the efficacy of behavioral treatment (BT) to memantine, a psychopharmacolog…
Chicago, United StatesEst. completion Jun 2026